Replies to post #204382 on Biotech Values

[DewDiligence]

AXON -12% on failure of Lundbeck AD drug with similar MoA:

http://endpts.com/lundbeck-otsuka-take-the-latest-hit-on-alzheimers-as-phiii-drug-flops/